Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
48.49
-2.10 (-4.15%)
Streaming Delayed Price
Updated: 12:05 PM EDT, Jul 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
231,443
Open
50.08
Bid (Size)
48.40 (200)
Ask (Size)
48.68 (100)
Prev. Close
50.59
Today's Range
48.34 - 50.30
52wk Range
15.80 - 94.90
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
June 05, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
May 26, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
-28.8%
-28.8%
1 Month
+12.6%
+12.6%
3 Month
-8.9%
-8.9%
6 Month
-37.8%
-37.8%
1 Year
+147.8%
+147.8%
More News
Read More
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
↗
May 24, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
↗
May 24, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Monashee Scales Back Its Bet on Structure Therapeutics
↗
May 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position
↗
May 10, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
May 07, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
April 27, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
↗
April 17, 2026
Via
MarketBeat
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
April 14, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via
MarketMinute
Topics
Economy
Main Street’s Revenge: The Great Rotation of 2026 Rewrites Market History
March 26, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout
March 25, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Great Rotation: Russell 2000 Outshines Mega-Caps as Domestic Small-Caps Take the Reins in 2026
March 24, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
↗
March 22, 2026
Via
The Motley Fool
3 Companies at the Forefront of the GLP-1 Pill Wars
↗
March 16, 2026
Via
MarketBeat
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
March 16, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million
↗
February 27, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
February 26, 2026
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position
↗
February 25, 2026
Via
The Motley Fool
Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit
↗
February 25, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction
↗
February 25, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
The current price of Structure Therapeutics Inc. - American Depositary Shares is 48.49
When was Structure Therapeutics Inc. - American Depositary Shares last traded?
The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 07/15/26 12:05 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
